The best of 2022
It’s here – the definitive list of our most-read blog posts, articles, and resources.
Designing successful rare disease clinical trials
An overview of challenges in trials for orphan drugs and how technology can help overcome them.
Looking back: what did we get right?
Did 2022 unfold as planned? We check in on our predictions.
How to strategically plan for orphan drug development
Key steps in developing an orphan drug, and how technology can streamline the process.
What’s on the mind of medical affairs?
Questions raised at Reuters Pharma Europe reveal what medical affairs is prioritizing for 2023.
What is an insight?
The difference between information and insights is distinct and increasingly important to life science leaders.
Medical affairs takes over: lessons from Reuters Pharma
How will technology enable medical affairs to lead their organizations more effectively?
Life science trends that will shape your work in 2023
Where is the industry headed, and how can you prepare? Our experts weigh in.
Checkpoints to consider during the drug development regulatory process
What milestones must a biopharma company achieve before and after a clinical trial?
How precision medicine can improve health outcomes
And what life science organizations can do to prepare.
